| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| MACRO domain containing 2 (MACROD2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY429950 | 100 ug | ORIGENE TECHNOLOGIES |
| MACRO domain containing 2 (MACROD2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY409100 | 100 ug | ORIGENE TECHNOLOGIES |
| Macrophage erythroblast attacher (MAEA), transcript variant 1 from ORIGENE TECHNOLOGIES | LY422781 | 100 ug | ORIGENE TECHNOLOGIES |
| RHPN1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH306645 | 10 ug | ORIGENE TECHNOLOGIES |
| RIB43A domain with coiled-coils 2 (RIBC2) from ORIGENE TECHNOLOGIES | LY414414 | 100 ug | ORIGENE TECHNOLOGIES |
| RHPN2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH305479 | 10 ug | ORIGENE TECHNOLOGIES |
| RIB43A domain with coiled-coils 1 (RIBC1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY422188 | 100 ug | ORIGENE TECHNOLOGIES |
| RIBC2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN400766 | 1 kit | ORIGENE TECHNOLOGIES |
| RIBC1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN407804 | 1 kit | ORIGENE TECHNOLOGIES |
| Ribc1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN514812 | 1 kit | ORIGENE TECHNOLOGIES |
| Ribc2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN514813 | 1 kit | ORIGENE TECHNOLOGIES |
| RIBC1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH307804 | 10 ug | ORIGENE TECHNOLOGIES |
| RIBC2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH300766 | 10 ug | ORIGENE TECHNOLOGIES |
| Riboflavin kinase (RFK) from ORIGENE TECHNOLOGIES | LY413132 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribokinase (RBKS) from ORIGENE TECHNOLOGIES | LY411756 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribonuclease/angiogenin inhibitor 1 (RNH1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY401028 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribonuclease/angiogenin inhibitor 1 (RNH1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY404324 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribonuclease/angiogenin inhibitor 1 (RNH1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY430918 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribonuclease/angiogenin inhibitor 1 (RNH1), transcript variant 3 from ORIGENE TECHNOLOGIES | LY404325 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribonuclease/angiogenin inhibitor 1 (RNH1), transcript variant 4 from ORIGENE TECHNOLOGIES | LY430919 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribonuclease/angiogenin inhibitor 1 (RNH1), transcript variant 4 from ORIGENE TECHNOLOGIES | LY404326 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribonuclease/angiogenin inhibitor 1 (RNH1), transcript variant 5 from ORIGENE TECHNOLOGIES | LY430920 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribonuclease/angiogenin inhibitor 1 (RNH1), transcript variant 5 from ORIGENE TECHNOLOGIES | LY404327 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribonuclease/angiogenin inhibitor 1 (RNH1), transcript variant 6 from ORIGENE TECHNOLOGIES | LY404328 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribonuclease/angiogenin inhibitor 1 (RNH1), transcript variant 7 from ORIGENE TECHNOLOGIES | LY404329 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribonuclease/angiogenin inhibitor 1 (RNH1), transcript variant 8 from ORIGENE TECHNOLOGIES | LY404330 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribonuclease H1 (RNASEH1) from ORIGENE TECHNOLOGIES | LY401027 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribonuclease H2, subunit A (RNASEH2A) from ORIGENE TECHNOLOGIES | LY416666 | 100 ug | ORIGENE TECHNOLOGIES |
| Lamin B1 (LMNB1) from ORIGENE TECHNOLOGIES | LY417217 | 100 ug | ORIGENE TECHNOLOGIES |
| Lamin B2 (LMNB2) from ORIGENE TECHNOLOGIES | LY409970 | 100 ug | ORIGENE TECHNOLOGIES |
| Lamin B receptor (LBR), transcript variant 1 from ORIGENE TECHNOLOGIES | LY419408 | 100 ug | ORIGENE TECHNOLOGIES |
| Lamin B receptor (LBR), transcript variant 2 from ORIGENE TECHNOLOGIES | LY405131 | 100 ug | ORIGENE TECHNOLOGIES |
| Lamin B receptor (LBR), transcript variant 2 from ORIGENE TECHNOLOGIES | LY430685 | 100 ug | ORIGENE TECHNOLOGIES |
| Laminin, alpha 3 (LAMA3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY424855 | 100 ug | ORIGENE TECHNOLOGIES |
| Laminin, alpha 4 (LAMA4), transcript variant 1 from ORIGENE TECHNOLOGIES | LY426227 | 100 ug | ORIGENE TECHNOLOGIES |
| Laminin, alpha 4 (LAMA4), transcript variant 2 from ORIGENE TECHNOLOGIES | LY419410 | 100 ug | ORIGENE TECHNOLOGIES |
| Laminin, beta 4 (LAMB4) from ORIGENE TECHNOLOGIES | LY415985 | 100 ug | ORIGENE TECHNOLOGIES |
| Laminin, beta 3 (LAMB3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY424856 | 100 ug | ORIGENE TECHNOLOGIES |
| Laminin, beta 3 (LAMB3), transcript variant 3 from ORIGENE TECHNOLOGIES | LY426828 | 100 ug | ORIGENE TECHNOLOGIES |
| Laminin, beta 2 (laminin S) (LAMB2) from ORIGENE TECHNOLOGIES | LY419412 | 100 ug | ORIGENE TECHNOLOGIES |
| Laminin, gamma 1 (formerly LAMB2) (LAMC1) from ORIGENE TECHNOLOGIES | LY419413 | 100 ug | ORIGENE TECHNOLOGIES |
| Laminin, gamma 3 (LAMC3) from ORIGENE TECHNOLOGIES | LY416892 | 100 ug | ORIGENE TECHNOLOGIES |
| Laminin, gamma 2 (LAMC2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY417224 | 100 ug | ORIGENE TECHNOLOGIES |
| Laminin, gamma 2 (LAMC2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY429255 | 100 ug | ORIGENE TECHNOLOGIES |
| Laminin, gamma 2 (LAMC2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY412907 | 100 ug | ORIGENE TECHNOLOGIES |
| LAMP2 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN200456 | 1 kit | ORIGENE TECHNOLOGIES |
| LAMP2 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN200456BN | 1 kit | ORIGENE TECHNOLOGIES |
| LAMP2 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN200456LP | 1 kit | ORIGENE TECHNOLOGIES |
| LAMP2 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN200456RB | 1 kit | ORIGENE TECHNOLOGIES |
| LAMP2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN400456 | 1 kit | ORIGENE TECHNOLOGIES |